Explore Business Standard
Explore Business Standard
The revenue stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.
Operating Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.
PBDT stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.
Profit Before Tax stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.
Net Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This represents a per cent year-on-year *(YoY) decline for the same year.
| Category | Q2 FY25-26 | Q2 FY24-25 | Change % | FY24-25 | FY23-24 | Change % |
|---|---|---|---|---|---|---|
| Total Revenue | 3,302.00 | 2,889.00 | 14.30 | 11,516.00 | 10,728.00 | 7.35 |
| Expenses | 2,232.00 | 1,950.00 | 14.46 | 7,819.00 | 7,360.00 | 6.24 |
| Other Income | -27.00 | -16.00 | 68.75 | 23.00 | 146.00 | -84.25 |
| Operating Profit | 21.00 | 48.00 | -56.25 | 3,720.00 | 3,514.00 | 5.86 |
| Depreciation | 204.00 | 198.00 | 3.03 | 795.00 | 808.00 | -1.61 |
| Interest | 48.00 | 64.00 | -25.00 | 252.00 | 354.00 | -28.81 |
| Profit Before Tax | 791.00 | 661.00 | 19.67 | 2,673.00 | 2,352.00 | 13.65 |
| Tax | 200.00 | 208.00 | -3.85 | 619.00 | 462.00 | 33.98 |
| Net Profit | 604.00 | 453.00 | 33.33 | 1,911.00 | 1,656.00 | 15.40 |
| Category | Q2 FY25-26 | Q2 FY24-25 | Change % | FY24-25 | FY23-24 | Change % |
|---|---|---|---|---|---|---|
| Total Revenue | 2,762.00 | 2,434.00 | 13.48 | 9,682.00 | 8,533.00 | 13.47 |
| Expenses | 1,703.00 | 1,513.00 | 12.56 | 6,131.00 | 5,643.00 | 8.65 |
| Other Income | -27.00 | -7.00 | 285.71 | 32.00 | 91.00 | -64.84 |
| Operating Profit | 2,113.00 | 1,856.00 | 13.85 | 3,583.00 | 2,981.00 | 20.19 |
| Depreciation | 189.00 | 190.00 | -0.53 | 760.00 | 761.00 | -0.13 |
| Interest | 37.00 | 54.00 | -31.48 | 213.00 | 303.00 | -29.70 |
| Profit Before Tax | 806.00 | 670.00 | 20.30 | 2,610.00 | 1,917.00 | 36.15 |
| Tax | 209.00 | 210.00 | -0.48 | 541.00 | 322.00 | 68.01 |
| Net Profit | 597.00 | 460.00 | 29.78 | 1,888.00 | 1,357.00 | 39.13 |
| Category | Q2 FY25-26 | Q1 FY25-26 | Change % |
|---|---|---|---|
| Total Revenue | 3,302.00 | 3,178.00 | 3.90 |
| Expenses | 2,232.00 | 2,146.00 | 4.01 |
| Other Income | -27.00 | -37.00 | -27.03 |
| Operating Profit | 21.00 | 19.00 | 10.53 |
| Depreciation | 204.00 | 201.00 | 1.49 |
| Interest | 48.00 | 56.00 | -14.29 |
| Profit Before Tax | 791.00 | 738.00 | 7.18 |
| Tax | 200.00 | 190.00 | 5.26 |
| Net Profit | 604.00 | 548.00 | 10.22 |
| Category | Q2 FY25-26 | Q1 FY25-26 | Change % |
|---|---|---|---|
| Total Revenue | 2,762.00 | 2,616.00 | 5.58 |
| Expenses | 1,703.00 | 1,637.00 | 4.03 |
| Other Income | -27.00 | -5.00 | 440.00 |
| Operating Profit | 2,113.00 | 2,011.00 | 5.07 |
| Depreciation | 189.00 | 187.00 | 1.07 |
| Interest | 37.00 | 45.00 | -17.78 |
| Profit Before Tax | 806.00 | 742.00 | 8.63 |
| Tax | 209.00 | 191.00 | 9.42 |
| Net Profit | 597.00 | 551.00 | 8.35 |
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Data not available.
| Company | 1 Day | 1 Week | 1 Month | 3 Months | 6 Month | 1 Year |
|---|---|---|---|---|---|---|
| Data Not Found | ||||||
Ahmedabad-based Torrent Pharmaceuticals has sought fair trade regulator CCI's clearance to acquire a majority stake in in J B Chemicals and Pharmaceuticals in a Rs 19,500-crore deal. After the completion of the deal, Torrent Pharmaceuticals will become India's second most valued pharma company. The development came after Torrent Pharmaceuticals in June this year announced the acquisition of a majority stake in J B Chemicals and Pharmaceuticals in a Rs 19,500-crore deal. "The proposed combination relates to acquisition of shareholding by the acquirer (Torrent Pharmaceuticals Ltd) in the target (J B Chemicals & Pharmaceuticals Ltd) and the subsequent amalgamation of the target with the acquirer," according to a notice filed with the Competition Commission of India (CCI). Torrent Pharmaceuticals is the flagship company of the Torrent group and is engaged in the business of manufacturing and sale of pharmaceutical formulations (FDFs) across therapeutic segments. J B Chemicals & ...
